1. Market Research
  2. > Pharmaceutical
  3. > Drug Discovery and Development Market Trends
  4. > Laryngeal Disease Global Clinical Trials Review, H2, 2015

Laryngeal Disease Global Clinical Trials Review, H2, 2015

Summary

GlobalData's clinical trial report, “Laryngeal Disease Global Clinical Trials Review, H2, 2015" provides an overview of Laryngeal Disease clinical trials scenario. This report provides top line data relating to the clinical trials on Laryngeal Disease. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). Global Data Clinical Trial Reports are generated using Global Data’s proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides a snapshot of the global clinical trials landscape
- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
- The Report provides enrollment trends for the past five years
- Report provides latest news for the past three months

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

- Assists in formulating key business strategies with regards to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional and country level

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table Of Contents

Laryngeal Disease Global Clinical Trials Review, H2, 2015
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Laryngeal Disease 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Clinical Trials by G7 Countries: Proportion of Laryngeal Disease to Ear Nose Throat Disorders Clinical Trials 13
Clinical Trials by Phase in G7 Countries 14
Clinical Trials in G7 Countries by Trial Status 15
Clinical Trials by Phase 16
In Progress Trials by Phase 17
Clinical Trials by Trial Status 18
Clinical Trials by End Point Status 19
Unaccomplished Trials of Laryngeal Disease 20
Subjects Recruited Over a Period of Time 22
Clinical Trials by Sponsor Type 23
Prominent Sponsors 24
Prominent Drugs 25
Clinical Trial Profiles 26
Clinical Trial Overview of Top Companies 26
Takeda Pharmaceutical Company Limited 26
Clinical Trial Overview of Takeda Pharmaceutical Company Limited 26
Atos Medical AB 27
Clinical Trial Overview of Atos Medical AB 27
Clinical Trial Overview of Top Institutes / Government 28
Vanderbilt University 28
Clinical Trial Overview of Vanderbilt University 28
University of Rostock 29
Clinical Trial Overview of University of Rostock 29
Boston University 30
Clinical Trial Overview of Boston University 30
Seoul National University Hospital 31
Clinical Trial Overview of Seoul National University Hospital 31
University Hospital Basel 32
Clinical Trial Overview of University Hospital Basel 32
University of L'Aquila 33
Clinical Trial Overview of University of L'Aquila 33
University of Turin 34
Clinical Trial Overview of University of Turin 34
Yokohama City University Medical Center 35
Clinical Trial Overview of Yokohama City University Medical Center 35
Five Key Clinical Profiles 36
Appendix 49
Abbreviations 49
Definitions 49
Research Methodology 50
Secondary Research 50
About GlobalData 51
Contact Us 51
Disclaimer 51
Source 52

List of Tables
Laryngeal Disease Therapeutics, Global, Clinical Trials by Region, 2015* 7
Laryngeal Disease Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8
Laryngeal Disease Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
Laryngeal Disease Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2015* 10
Laryngeal Disease Therapeutics Clinical Trials, Europe, Top Countries, 2015* 11
Laryngeal Disease Therapeutics Clinical Trials, North America, Top Countries, 2015* 12
Proportion of Laryngeal Disease to Ear Nose Throat Disorders Clinical Trials, G7 Countries (%), 2015* 13
Laryngeal Disease Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 14
Laryngeal Disease Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 15
Laryngeal Disease Therapeutics, Global, Clinical Trials by Phase, 2015* 16
Laryngeal Disease Therapeutics, Global, Clinical Trials In Progress by Phase 2015* 17
Laryngeal Disease Therapeutics, Global, Clinical Trials by Trial Status, 2015* 18
Laryngeal Disease Therapeutics Clinical Trials, Global, by End Point Status, 2015* 19
Laryngeal Disease Therapeutics, Global, Withdrawn Clinical Trials, 2015* 20
Laryngeal Disease Therapeutics, Global, Terminated Clinical Trials, 2015* 21
Laryngeal Disease Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 22
Laryngeal Disease Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015* 23
Laryngeal Disease Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 24
Laryngeal Disease Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 25
Laryngeal Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Takeda Pharmaceutical Company Limited, 2015* 26
Laryngeal Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Atos Medical AB, 2015* 27
Laryngeal Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Vanderbilt University, 2015* 28
Laryngeal Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Rostock, 2015* 29
Laryngeal Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Boston University, 2015* 30
Laryngeal Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Seoul National University Hospital, 2015* 31
Laryngeal Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by University Hospital Basel, 2015* 32
Laryngeal Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by University of L'Aquila, 2015* 33
Laryngeal Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Turin, 2015* 34
Laryngeal Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Yokohama City University Medical Center, 2015* 35

List of Figures
Laryngeal Disease Therapeutics, Global, Clinical Trials by Region (%), 2015* 7
Laryngeal Disease Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8
Laryngeal Disease Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
Laryngeal Disease Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2015* 10
Laryngeal Disease Therapeutics Clinical Trials, Europe, Top Countries (%), 2015* 11
Proportion of Laryngeal Disease to Ear Nose Throat Disorders Clinical Trials, G7 Countries (%), 2015* 13
Laryngeal Disease Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 14
Laryngeal Disease Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 15
Laryngeal Disease Therapeutics, Global, Clinical Trials by Phase (%), 2015* 16
Laryngeal Disease Therapeutics, Global, Clinical Trials In Progress by Phase, 2015* 17
Laryngeal Disease Therapeutics, Global, Clinical Trials by Trial Status, 2015* 18
Laryngeal Disease Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 22
Laryngeal Disease Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015* 23
Laryngeal Disease Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 24
Laryngeal Disease Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 25
GlobalData Methodology 50

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

  • $ 5650
  • Industry report
  • August 2016
  • by MarketsandMarkets

The global clinical trial management system (CTMS) market is estimated to grow at a CAGR of 11.5% from 2016 to 2021, to reach USD 920.0 billion by 2021. The adoption of CTMS software is on the rise across ...

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

  • $ 5650
  • Industry report
  • October 2016
  • by MarketsandMarkets

The global CRO services market is estimated to grow at a CAGR of 7.4% from 2016 to 2021, to reach USD 41.86 billion by 2021 from USD 29.29 billion in 2016. Growth in this market is primarily attributed ...

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

  • $ 4157
  • Industry report
  • November 2016
  • by Stratistics MRC

According to Stratistics MRC, the Global Clinical Trial Management System (CTMS) market is expected to grow from $493.58 million in 2015 to reach $1118.58 million by 2022 with a CAGR of 12.4%. Huge research ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.